can tirzepatide cause menstrual cycle problems and Changes: Clinical Evidence – PlexusDx Can Weight Loss Pens Affect

Saxenda, also an incretin mimetic, was approved for obesity with the active ingredient liraglutide (and previously approved for type 2 diabetes under the name Victoza) as a daily injection

The key difference

No large-scale, randomized placebo-controlled trials have established efficacy or formal indications for BPC-157

Clinical check-ins and symptom logs allowed clinicians to slow escalation rather than stop therapy, preserving continuity and reducing avoidable discontinuations

Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, Nilsson B, Mller JE, Hjort J, Rasmussen J

PMID: 30 Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group